Missing/wrong data?
Log in to edit
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
scientific article published on October 2017
Author/s
author: Rocío García-Carbonero, Weilan Ye, Jacek Jassem, Fadi Braiteh, Herbert Hurwitz, Ira Gore, Eric Van Cutsem, Niall Tebbutt
Work details
Publication date
October 1, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.